Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serial Response and Biomarker-Guided Steroid Taper for Children With GVHD
NCT05090384Phase 2Completed
- Start
- Oct 2022
- Primary completion
- Mar 2025
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of prednisone in Acute Graft-Versus-Host Disease (aGvHD). Started Oct 2022; status: completed.
02
Drugs
prednisone
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT05090384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05090384.